UDG Healthcare acquires Putnam Associates and Incisive Health

Paul Hudson is to succeed Olivier Brandicourt as Chief Executive Officer at Sanofi. 

UDG Healthcare plc has announced the acquisition of Putnam Associates, a US-based strategic management healthcare consultancy and Incisive Health, a UK-based healthcare policy and communications consultancy.

Both focused within the healthcare industry, Putnam strengthens Ashfield’s growing advisory pillar, adding significant expertise in product commercialisation, pricing, reimbursement and market access strategy. Incisive Health adds specialist capability in the growing area of public health advocacy, supporting clients to secure marketing access for their brands, in addition to wider communications services.

Based in the US, Putnam is a specialist consultancy focused on product commercialisation strategy, exclusively for the life sciences industry. Putnam primarily offers consultancy services across the product life cycle with particular strengths in product commercialisation, pricing and reimbursement and market access strategy. Over the past 10 years, Putnam has advised on the commercialisation of several products that have achieved blockbuster sales status in the US.

Putnam adds significant capabilities and scale to Ashfield’s existing advisory pillar in the US as well as delivering a step change in Ashfield’s capabilities in pricing, reimbursement and market access. Putnam also complements Ashfield’s existing advisory offering, including STEM, Vynamic and SmartAnalyst, which were acquired between 2016 and 2018.

Incisive Health is a UK-based healthcare communications consultancy, which specialises in healthcare policy, public affairs and communication services. Across its head office in London and an office in Brussels, the consultancy employs 36 people and provides a suite of consultancy and communications services including clinical advocacy, corporate and digital communications, direct payer engagement, public affairs, stakeholder campaigning, strategic and policy development and training programmes. Incisive Health has a diversified client base of predominately pharmaceutical and biotech companies.

Incisive Health significantly strengthens Ashfield Communications’ capabilities in the UK and mainland Europe, specifically in dedicated policy and market access communications.